Demonstration of a relaxin receptor and relaxin-stimulated tyrosine phosphorylation in human lower uterine segment fibroblasts

Smita Palejwala, Daniel Stein, Andrea Wojtczuk, Gerson Weiss, Laura T. Goldsmith

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Abstract

To elucidate the mechanism of relaxin action, we studied the binding characteristics of human relaxin and its effects on intracellular concentrations of cAMP and tyrosine phosphorylation of cellular proteins in a model system of human cervix, human lower uterine segment fibroblasts. Human relaxin labeled with 125I bound specifically to a single class of high- affinity relaxin binding sites, distinct from insulin receptors, with a mean (±SEM) dissociation constant (K(d)) of 4.36 ± 1.7 x 109 M and a mean of 3220 ± 557 binding sites per cell in human lower uterine segment fibroblasts. Relaxin, in quantities that were shown previously to stimulate intracellular levels of cAMP in other cell types, had no effect on intracellular levels of cAMP in human lower uterine segment fibroblasts even in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methyl- xanthine. (IBMX). Incubation of the cells with relaxin caused a significant increase in tyrosine phosphorylation of a protein with an apparent M(r) of approximately 220 kDa in these cells. In concert with results of recount studies that demonstrated that the M(r) of the relaxin receptor is approximately 220 kDa, our data suggest that the phosphorylated protein is likely to be the relaxin receptor.

Original languageEnglish
Pages (from-to)1208-1212
Number of pages5
JournalEndocrinology
Volume139
Issue number3
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Dive into the research topics of 'Demonstration of a relaxin receptor and relaxin-stimulated tyrosine phosphorylation in human lower uterine segment fibroblasts'. Together they form a unique fingerprint.

Cite this